Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F

Gauzy Ltd. (NASDAQ: GAUZ) said Nasdaq notified it on May 19, 2026 that it is not compliant with Nasdaq Rule 5250(c)(1) due to a delayed filing of its 2025 Form 20-F. Nasdaq said the notice has no immediate impact on trading, but the company will be listed as non-compliant. Gauzy has 60 days (until July 20, 2026) to submit a plan.

Original reporting
Published May 26, 2026, 3:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 4:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F — source image
Decision brief

The 30-second read

$GAUZBearishHigh
01

Why it matters

The key trading variable becomes whether Nasdaq accepts a remediation plan and whether the 20-F is filed within any granted cure/exception window; failure increases delisting risk.

02

Market read

A compliance notice tied to SEC reporting timeliness can quickly reprice delisting risk and liquidity for GAUZ.

03

What to watch

Market may focus more on the separate minimum bid price non-compliance and the company’s ability to secure funding/complete filings, which could dominate the stock’s reaction.

Relevance 9/10Timing: 60-day plan deadline (July 20, 2026) with potential up to 180-day extension if accepted.

Background

Nasdaq issued a second notice: delayed 2025 Form 20-F filing (Rule 5250(c)(1)) on top of prior minimum bid price non-compliance.

Company-level read

Ticker impact

$GAUZBearishHigh confidence
Context

Gauzy received a Nasdaq notice for delayed filing of its 2025 Form 20-F, risking continued listing and potential delisting.

Expected impact

Near-term downside bias and higher volatility as investors price in compliance-plan odds and reporting delays.

Evidence & confidence

The company is explicitly flagged for Nasdaq Rule 5250(c)(1) due to a delayed 20-F, with delisting risk if it fails to regain compliance by the stated deadlines.

Market effects

Raises risk premium for other small-cap issuers with late SEC filings and Nasdaq compliance exposure.

Israel-domiciled Nasdaq listings may see investor scrutiny on disclosure timeliness.

Limited direct global read-across; primarily a US listing/compliance event.

Counterpoint

The notice states no immediate effect on trading and the company intends to submit a compliance plan, which can reduce worst-case delisting probability.

Key entities

  • Gauzy Ltd.

    Nasdaq-listed company receiving the delayed 20-F non-compliance notice and required to submit a compliance plan.

  • Nasdaq Listing Qualifications Department

    The Nasdaq unit that issued the notice under Listing Rule 5250(c)(1).

  • The Nasdaq Stock Market LLC

    The exchange whose listing rules govern compliance and potential delisting outcomes.

  • SEC

    The SEC receives the Form 20-F; the delay is the trigger for Nasdaq non-compliance.

Related articles

$GAUZMed

GAUZY LTD: Gauzy Announces Court-Approved Resolution of Legacy Debt Following Overwhelming 98.96% Creditor Vote, Including 100% of Secured Lenders

Gauzy Ltd. (NASDAQ: GAUZ) announced a court-approved debt settlement resolving $61M in legacy liabilities, with 98.96% creditor approval. The company secured $7M in new equity capital and will make monthly payments over six years. The settlement lifts insolvency stay and resolves legal proceedings.

$GAUZMedAI 8/10

Smart glass co Gauzy seeks debt settlement

Gauzy (Nasdaq: GAUZ) reported to investors and creditors on a proposed debt settlement after former employees sought insolvency proceedings. The plan includes a $7 million PIPE and two repayment options: an exit event generating over $330 million to repay all debts, or paying 25% of GAAP net profit annually until repaid. Gauzy has not filed since Q2 2025.

$BACHigh

Bank of America CEO addresses a troubling banking problem

Bank of America (BAC) faces $1.21B in penalties for failing to report $5B in suspicious transactions, including potential money laundering. The Treasury Department cited ongoing compliance failures. BAC's stock fell 2% in after-hours trading on Oct. 13, with a 4.49% YTD decline. CEO Brian Moynihan acknowledged the issues and ongoing remediation efforts. Q3 earnings showed $6.9B net income and 3% revenue growth, with full-year guidance raised to 8%.

$EWMed

Four Lots of Edwards Mitral Valve Delivery Systems Pulled After Balloon Bursts Linked to One Patient Death

Edwards Lifesciences recalled four lots of its Commander M delivery system after balloon bursts during procedures, linked to one death and one injury. The FDA issued an Early Alert, advising hospitals to stop using the affected lots. The system is used for transcatheter mitral valve replacement in patients unsuitable for surgery. Edwards shares were down less than 1% on Oct. 16.